[1] Gelderblom W C, Rheeder J P, Leggott N, et al. Fumonisin contamination of a corn sample associated with the induction of hepatocarcinogenesis in rats-role of dietary deficiencies[J]. Food Chem Toxicol, 2004, 42(3): 471-479

[2] Marasas W F, Jaskiewicz K, Venter F S, et al. Fusarium moniliforme contamination of maize in oesophageal cancer areas in Transkei[J]. S Afr Med J, 1988, 74(3): 110-114

[3] Yoshizawa T, Yamashita A, Luo Y. Fumonisin occurrence in corn from high- and low-risk areas for human esophageal cancer in China[J]. Appl Environ Microbiol, 1994, 60(5): 1626-1629

[4] Chu F S, Li G Y. Simultaneous occurrence of fumonisin B1 and other mycotoxins in moldy corn collected from the People's Republic of China in regions with high incidences of esophageal cancer[J]. Appl Environ Microbiol, 1994, 60(3): 847-852

[5] Sun G, Wang S, Hu X, et al. Fumonisin B1 contamination of home-grown corn in high-risk areas for esophageal and liver cancer in China[J]. Food Addit Contam, 2007, 24(2): 181-185

[6] 邱茂锋，刘秀梅，王玉华，等. 某食管癌高发区人群伏马菌素摄入量及尿二氢神经鞘氨醇/神经鞘氨醇比值的调查[J]. 卫生研究, 2001, 30(6): 365-367

[7] Wang H, Wei H, Ma J, et al. The fumonisin B1 content in corn from North China, a high-risk area of esophageal cancer[J]. J Environ Pathol Toxicol Oncol, 2000, 19(1-2): 139-141

[8] Alizadeh A M, Rohandel G, Roudbarmohammadi S, et al. Fumonisin B1 contamination of cereals and risk of esophageal cancer in a high risk area in northeastern Iran[J]. Asian Pac J Cancer Prev, 2012, 13(6): 2625-2628

[9] Wang S K, Liu S, Yang L G, et al. Effect of fumonisin B1 on the cell cycle of normal human liver cells[J]. Mol Med Rep, 2013, 7(6): 1970-1976

[10] Bondy G S, Barker M G, Lombaert G A, et al. A comparison of clinical, histopathological and cell-cycle markers in rats receiving the fungal toxins fumonisin B1 or fumonisin B2 by intraperitoneal injection[J]. Food Chem Toxicol, 2000, 38(10): 873-886

[11] Ho Y S, Chen C H, Wang Y J, et al. Tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) induces cell proliferation in normal human bronchial epithelial cells through NFkappaB activation and cyclin D1 up-regulation[J]. Toxicol Appl Pharmacol, 2005, 205(2): 133-148

[12] Hwang H C, Clurman B E. Cyclin E in normal and neoplastic cell cycles[J]. Oncogene, 2005, 24(17): 2776-2786

[13] Nanos-Webb A, Jabbour N A, Multani A S, et al. Targeting low molecular weight cyclin E (LMW-E) in breast cancer[J]. Breast Cancer Res Treat, 2012, 132(2): 575-588

[14] Risch H A. Cyclin E overexpression relates to ovarian cancer histology but not to risk factors[J]. Cancer Epidemiol Biomarkers Prev, 2008, 17(7): 1841-1842

[15] O'Regan E M, Toner M E, Finn S P, et al. p16(INK4A) genetic and epigenetic profiles differ in relation to age and site in head and neck squamous cell carcinomas[J]. Hum Pathol, 2008, 39(3): 452-458

[16] Zhang Y, Dickman M B, Jones C. The mycotoxin fumonisin B1 transcriptionally activates the p21 promoter through a cis-acting element containing two Sp1 binding sites[J]. J Biol Chem, 1999, 274(18): 12367-12371

[17] Zhang W G, Wu Q M, Yu J P, et al. Adenovirus expressing p27kip1 suppresses growth of established esophageal carcinoma xenografts[J]. World J Gastroenterol, 2005, 11(42): 6582-6586